The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review.

CONCLUSION: Results of this meta-analysis allude CTCs as potent prognostic marker in primary breast cancers prior to any systemic therapy especially when it is studied via CellSearch ® administration, considering that the more the CTCs, the greater the death and relapse rates. PMID: 30843493 [PubMed - as supplied by publisher]
Source: Current Stem Cell Research and Therapy - Category: Stem Cells Authors: Tags: Curr Stem Cell Res Ther Source Type: research